Who Buys Ibrutinib from India — 210 Importers Behind a $1.0M Market
India's ibrutinib import market is served by 210 active buyers who collectively imported $1.0M across 560 shipments. TO THE, (BRAZIL) leads with a 14.2% market share, followed by VALTER LUIZ CACHELLI and ACI LOGISTICS DWC LLC. The top 5 buyers together control 34.5% of total import value, reflecting a moderately competitive buyer landscape.
Top Ibrutinib Importers — Ranked by Import Value
TO THE, (BRAZIL) is the leading ibrutinib importer from India, holding a 14.2% share of the $1.0M market across 560 shipments from 210 buyers. The top 5 buyers — TO THE, (BRAZIL), VALTER LUIZ CACHELLI (BRAZIL), ACI LOGISTICS DWC LLC (UKRAINE), TO THE (BRAZIL), SKIN LINE LOGISTIC (IRAQ) — collectively control 34.5% of total import value.
Top Ibrutinib Buyers & Importers
Ranked by import value · 210 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | TO THE,BRAZIL IBRUTINIBIBRUTINIB4650GMS6NITIB 140 MG | $142.8K | 5 | 14.2% |
| 2 | VALTER LUIZ CACHELLIBRAZIL | $70.8K | 5 | 7.0% |
| 3 | ACI LOGISTICS DWC LLCUKRAINE IBRUTINIBIBRUTINIB4650GMS6IBRUTINIB 140MG CAP - NITIB | $55.8K | 5 | 5.5% |
| 4 | TO THEBRAZIL IBRUTINIBIBRUTINIB4650GMS6NITIB 140 MG | $47.5K | 5 | 4.7% |
| 5 | SKIN LINE LOGISTICIRAQ NITIB CAP.IBRUTINIB CAPSULES 140MG1*30 CAP. AS PER DOCUMENTNITIB TAB. IBRUTINIB CAPSULES 140MG AS PER INVOICENITIB 140 MGIBRUTINIB CAP. 140 MG AS PER INVOICE | $30.6K | 5 | 3.0% |
| 6 | INVOICE RAISED TOUNITED ARAB EMIRATES NITIB 140 MGNITIB 140MGIBRUTINIB CAPSULES 140MG | $29.5K | 5 | 2.9% |
| 7 | DIRCE CANDIDA DA SILVABRAZIL | $17.7K | 5 | 1.8% |
| 8 | TO THE CONCERN PERSONBRAZIL IBRUTINIBIBRUTINIB4650GMS6NITIB 140 MG | $15.1K | 5 | 1.5% |
| 9 | JACINTO FERREIRA DA SILVABRAZIL | $11.3K | 5 | 1.1% |
| 10 | MANOEL JOAQUIM DA SILVABRAZIL | $9.8K | 5 | 1.0% |
| 11 | ANTONIO LINS SOBRINHOBRAZIL | $9.8K | 5 | 1.0% |
| 12 | MARIA LUCIA TAVARES DE OLIVEIRABRAZIL | $9.7K | 5 | 1.0% |
| 13 | THE PURCHASE MANAGERCHILE NITIB 140 MGNITIB 140MGIBRUTINIB CAPSULES 140MG | $9.4K | 5 | 0.9% |
| 14 | MARINA JAMESNEW ZEALAND | $8.7K | 5 | 0.9% |
| 15 | TO THE PURCHASE DEPARMENTSWITZERLAND IBRUTINIBIBRUTINIB4650GMS6NITIB 140 MG | $8.7K | 5 | 0.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Ibrutinib — and from which countries?
Flow of Ibrutinib exports from India: each country's share and the named importers behind the numbers
Ibrutinib — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil emerges as the first largest importing country, achieving a total trade value of $536.6K through 71 shipments. This represents a market share of 53.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• TO THE, - $142.8K (26.6% of country's total business)
• VALTER LUIZ CACHELLI - $70.8K (13.2% of country's total business)
• TO THE - $47.5K (8.9% of country's total business)
• DIRCE CANDIDA DA SILVA - $17.7K (3.3% of country's total business)
• TO THE CONCERN PERSON - $15.1K (2.8% of country's total business)
• Rest of Brazil's importers - $242.7K (45.2% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $7.6K, indicating premium pricing strategy compared to the market average of $1.8K.
Brazil is a key market for Ibrutinib imports, representing 53.3% of total trade value.
2Ukraine
Ukraine emerges as the second largest importing country, achieving a total trade value of $56.5K through 2 shipments. This represents a market share of 5.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ukraine has a diverse importer base, with their top importers including:
• ACI LOGISTICS DWC LLC - $55.8K (98.9% of country's total business)
Key Insight: Ukraine demonstrates strong market positioning with an average shipment value of $28.2K, indicating premium pricing strategy compared to the market average of $1.8K.
Ukraine is a key market for Ibrutinib imports, representing 5.6% of total trade value.
3Turkey
Turkey emerges as the third largest importing country, achieving a total trade value of $41.5K through 0 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Turkey demonstrates strong market positioning with an average shipment value of $41.5K, indicating premium pricing strategy compared to the market average of $1.8K.
Turkey is a key market for Ibrutinib imports, representing 4.1% of total trade value.
4Iraq
Iraq emerges as the fourth largest importing country, achieving a total trade value of $37.5K through 15 shipments. This represents a market share of 3.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Iraq has a diverse importer base, with their top importers including:
• SKIN LINE LOGISTIC - $30.6K (81.5% of country's total business)
Key Insight: Iraq demonstrates strong market positioning with an average shipment value of $2.5K, indicating premium pricing strategy compared to the market average of $1.8K.
Iraq is a key market for Ibrutinib imports, representing 3.7% of total trade value.
5Jamaica
Jamaica emerges as the fifth largest importing country, achieving a total trade value of $32.7K through 0 shipments. This represents a market share of 3.3% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Jamaica demonstrates strong market positioning with an average shipment value of $32.7K, indicating premium pricing strategy compared to the market average of $1.8K.
Jamaica is a key market for Ibrutinib imports, representing 3.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Ibrutinib buyer market intelligence
1Buyer Segment Analysis
The importation of Ibrutinib from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: These entities purchase Ibrutinib in bulk to supply to healthcare providers and pharmacies. In our data, "ACI LOGISTICS DWC LLC" from Ukraine, with imports totaling $0.06 million, likely falls into this category. Distributors typically place large, periodic orders to maintain inventory levels and meet market demand.
Hospital Groups: These are networks of hospitals that procure medications directly for patient treatment. While specific hospital groups are not explicitly named in the top buyers, entities like "TO THE" from Brazil, with imports totaling $0.14 million, may represent such groups. Hospital groups often have consistent purchasing patterns aligned with patient treatment schedules.
Retail Chains: Pharmacy chains that purchase medications for retail sale. The data does not specify retail chains among the top buyers. Retail chains usually order based on consumer demand and stock turnover rates.
Government Procurement: This includes national health services and international organizations like UNICEF and the Global Fund that procure medications for public health programs. The provided data does not indicate any government procurement entities among the top buyers. Such buyers often engage in tender-based purchasing with large, infrequent orders.
Re-exporters: Companies that import medications to export them to other markets. "SKIN LINE LOGISTIC" from Iraq, with imports totaling $0.03 million, may function as a re-exporter. Re-exporters' purchasing patterns depend on the demands of their target export markets.
Contract Manufacturers: Firms that import active pharmaceutical ingredients or finished products for further processing or packaging. The data does not specify contract manufacturers among the top buyers. These buyers typically order based on production schedules and contractual obligations.
Country-Specific Import Regulations
TransData Nexus Ibrutinib buyer market intelligence
1Country-Specific Import Regulations
- 1Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
- 2Import Registration Process: Importers must obtain a Sanitary Authorization from ANVISA, which involves submitting a dossier with product information, manufacturing details, and clinical data.
- 3Estimated Timeline: The registration process typically takes 6 to 12 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 14% import duty.
Brazil:
- 1Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
- 2Import Registration Process: Importers must register the product with the SMDC by submitting a registration dossier, including quality, safety, and efficacy data.
- 3Estimated Timeline: The registration process usually takes 6 to 9 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 5% import duty.
Ukraine:
- 1Regulatory Authority: Turkish Medicines and Medical Devices Agency (TİTCK).
- 2Import Registration Process: Importers must obtain a product license from TİTCK, requiring submission of a registration dossier with comprehensive product information.
- 3Estimated Timeline: The registration process typically takes 8 to 12 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 6% import duty.
Turkey:
- 1Regulatory Authority: Iraqi Ministry of Health, Directorate of Technical Affairs.
- 2Import Registration Process: Importers must register the product with the Directorate by submitting a dossier containing product specifications, manufacturing details, and clinical data.
- 3Estimated Timeline: The registration process usually takes 9 to 12 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 10% import duty.
Iraq:
- 1Regulatory Authority: Pharmacy Council of Jamaica.
- 2Import Registration Process: Importers must register the product with the Pharmacy Council by submitting a registration dossier, including product information and evidence of Good Manufacturing Practice compliance.
- 3Estimated Timeline: The registration process typically takes 6 to 8 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 5% import duty.
Jamaica:
Demand Drivers & Market Opportunity
TransData Nexus Ibrutinib buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Ibrutinib in importing countries is primarily driven by the prevalence of B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). According to the World Health Organization (WHO), the global incidence of CLL is approximately 4.5 per 100,000 individuals annually, with higher rates observed in regions like Europe and North America. This underscores a significant patient population requiring targeted therapies like Ibrutinib.
Government healthcare programs and the expansion of universal health coverage also contribute to increased demand. Countries implementing such programs aim to provide access to essential medicines, including those listed on the WHO Essential Medicines List, which features Ibrutinib for the treatment of CLL and MCL. Additionally, tender-based purchasing mechanisms employed by national health services and international organizations facilitate bulk procurement, ensuring a steady supply of Ibrutinib to meet patient needs. Our data indicates 210 buyers across 60 countries, reflecting a broad and growing market for Ibrutinib imported from India.
Common Questions — Ibrutinib Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ibrutinib buyer importing from India?
Based on import volume and value, TO THE, (BRAZIL) leads with $142.8K in imports and a 14.2% market share — the highest of any single ibrutinib importer. VALTER LUIZ CACHELLI (BRAZIL) and ACI LOGISTICS DWC LLC (UKRAINE) are the next largest buyers.
QHow many companies buy ibrutinib from India?
There are 210 active ibrutinib buyers importing from India, with a combined market of $1.0M across 560 shipments to 60 countries. The top 5 buyers hold 34.5% of total import value, while the remaining 205 buyers handle the other 65.5%.
QWhich countries import the most ibrutinib from India?
The top importing countries for ibrutinib from India are Brazil (53.3%), Ukraine (5.6%), Turkey (4.1%), Iraq (3.7%), Jamaica (3.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of ibrutinib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for ibrutinib from India?
The average import transaction value for ibrutinib from India is $1.8K, with an average unit price of $742.98 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Ibrutinib buyer market intelligence
1Buyer Segment Analysis
The importation of Ibrutinib from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: These entities purchase Ibrutinib in bulk to supply to healthcare providers and pharmacies. In our data, "ACI LOGISTICS DWC LLC" from Ukraine, with imports totaling $0.06 million, likely falls into this category. Distributors typically place large, periodic orders to maintain inventory levels and meet market demand.
Hospital Groups: These are networks of hospitals that procure medications directly for patient treatment. While specific hospital groups are not explicitly named in the top buyers, entities like "TO THE" from Brazil, with imports totaling $0.14 million, may represent such groups. Hospital groups often have consistent purchasing patterns aligned with patient treatment schedules.
Retail Chains: Pharmacy chains that purchase medications for retail sale. The data does not specify retail chains among the top buyers. Retail chains usually order based on consumer demand and stock turnover rates.
Government Procurement: This includes national health services and international organizations like UNICEF and the Global Fund that procure medications for public health programs. The provided data does not indicate any government procurement entities among the top buyers. Such buyers often engage in tender-based purchasing with large, infrequent orders.
Re-exporters: Companies that import medications to export them to other markets. "SKIN LINE LOGISTIC" from Iraq, with imports totaling $0.03 million, may function as a re-exporter. Re-exporters' purchasing patterns depend on the demands of their target export markets.
Contract Manufacturers: Firms that import active pharmaceutical ingredients or finished products for further processing or packaging. The data does not specify contract manufacturers among the top buyers. These buyers typically order based on production schedules and contractual obligations.
Country-Specific Import Regulations
TransData Nexus Ibrutinib buyer market intelligence
1Country-Specific Import Regulations
- 1Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
- 2Import Registration Process: Importers must obtain a Sanitary Authorization from ANVISA, which involves submitting a dossier with product information, manufacturing details, and clinical data.
- 3Estimated Timeline: The registration process typically takes 6 to 12 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 14% import duty.
Brazil:
- 1Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
- 2Import Registration Process: Importers must register the product with the SMDC by submitting a registration dossier, including quality, safety, and efficacy data.
- 3Estimated Timeline: The registration process usually takes 6 to 9 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 5% import duty.
Ukraine:
- 1Regulatory Authority: Turkish Medicines and Medical Devices Agency (TİTCK).
- 2Import Registration Process: Importers must obtain a product license from TİTCK, requiring submission of a registration dossier with comprehensive product information.
- 3Estimated Timeline: The registration process typically takes 8 to 12 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 6% import duty.
Turkey:
- 1Regulatory Authority: Iraqi Ministry of Health, Directorate of Technical Affairs.
- 2Import Registration Process: Importers must register the product with the Directorate by submitting a dossier containing product specifications, manufacturing details, and clinical data.
- 3Estimated Timeline: The registration process usually takes 9 to 12 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 10% import duty.
Iraq:
- 1Regulatory Authority: Pharmacy Council of Jamaica.
- 2Import Registration Process: Importers must register the product with the Pharmacy Council by submitting a registration dossier, including product information and evidence of Good Manufacturing Practice compliance.
- 3Estimated Timeline: The registration process typically takes 6 to 8 months.
- 4Import Tariff/Duty: Pharmaceutical products under HS code 30049099 are subject to a 5% import duty.
Jamaica:
Demand Drivers & Market Opportunity
TransData Nexus Ibrutinib buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Ibrutinib in importing countries is primarily driven by the prevalence of B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). According to the World Health Organization (WHO), the global incidence of CLL is approximately 4.5 per 100,000 individuals annually, with higher rates observed in regions like Europe and North America. This underscores a significant patient population requiring targeted therapies like Ibrutinib.
Government healthcare programs and the expansion of universal health coverage also contribute to increased demand. Countries implementing such programs aim to provide access to essential medicines, including those listed on the WHO Essential Medicines List, which features Ibrutinib for the treatment of CLL and MCL. Additionally, tender-based purchasing mechanisms employed by national health services and international organizations facilitate bulk procurement, ensuring a steady supply of Ibrutinib to meet patient needs. Our data indicates 210 buyers across 60 countries, reflecting a broad and growing market for Ibrutinib imported from India.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 210 global importers of Ibrutinib identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 560 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 60 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
560 Verified Shipments
210 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists